These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 6796317)

  • 21. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
    Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
    Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amyloid neuropathy associated with a benign monoclonal gammopathy (lambda light chains)].
    Graveleau P; Dairou R; Tritschler JC; Hénin D; Masson M; Cambier J
    Rev Neurol (Paris); 1978 Dec; 134(12):773-80. PubMed ID: 224439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin-related (AL) amyloidosis.
    Husby G
    Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous amyloidosis.
    Borowicz J; Gillespie M; Miller R
    Skinmed; 2011; 9(2):96-100; quiz 101. PubMed ID: 21548513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
    Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
    Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bullous poikilodermatitic amyloidosis of the skin with junctional bulla development in IgG light chain plasmacytoma of the lambda type. Histology, immunohistology and electron microscopy].
    Winzer M; Ruppert M; Baretton G; Quast U; Wolff HH
    Hautarzt; 1992 Apr; 43(4):199-204. PubMed ID: 1597368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chemical classification of amyloid. Correlation with different clinical types of amyloidosis.
    Husby G
    Scand J Rheumatol; 1980; 9(1):60-4. PubMed ID: 6769151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
    Gallo G; Picken M; Frangione B; Buxbaum J
    Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis.
    Block PJ; Skinner M; Benson MD; Cohen AS
    Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
    Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal rheumatoid factor (IgG lambda) its association with amyloid deposits containing lambda light chains.
    Singh G; Myerowitz RL; Chervenick PA; Kelly RH
    Arch Pathol Lab Med; 1981 Nov; 105(11):586-9. PubMed ID: 6794541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-restricted amyloidoma of immunoglobulin lambda-light chain origin clinically resembling multiple sclerosis.
    Linke RP; Gerhard L; Lottspeich F
    Biol Chem Hoppe Seyler; 1992 Dec; 373(12):1201-9. PubMed ID: 1292505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of tissue fixation on the microextraction and identification of amyloid proteins.
    Röcken C; Wilhelm S
    J Lab Clin Med; 2005 Oct; 146(4):244-50. PubMed ID: 16194686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V.
    Sletten K; Husby G; Natvig JB
    Scand J Immunol; 1974; 3(6):833-6. PubMed ID: 4218364
    [No Abstract]   [Full Text] [Related]  

  • 37. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Apr; 245(3):713-6. PubMed ID: 9588180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of systemic lambda-light chain amyloidosis in a patient with gamma-heavy chain deposition disease during long-term follow-up.
    Komatsuda A; Maki N; Wakui H; Ohtani H; Hatakeyama T; Yasuda T; Nakamoto Y; Imai H; Sawada K
    Nephrol Dial Transplant; 2005 Feb; 20(2):434-7. PubMed ID: 15673693
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
    Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
    Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.